Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold L Moses

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Oncogene|March 1, 2005
Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomyJudith Romero-Gallo, Elif G Sozmen, Anna Chytil, et al.
Cancer Research|January 4, 2014
ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to boneAmanda G Hansen, Shanna A Arnold, Ming Jiang, et al.
Plos One|November 11, 2020
Inhibition of transforming growth factor-β signaling in myeloid cells ameliorates aortic aneurysmal formation in Marfan syndromeHironori Hara, Sonoko Maemura, Takayuki Fujiwara, et al.
The Oncologist|March 13, 2020
Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology DrugsErin P Balogh, Andrew B Bindman, S Gail Eckhardt, et al.
Molecular Cancer Therapeutics|December 21, 2002
Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylaseKeith B Glaser, Junling Li, Mary E Aakre, et al.
Stem Cell Reports|January 27, 2015
Age- and pregnancy-associated DNA methylation changes in mammary epithelial cellsSung Jin Huh, Kendell Clement, David Jee, et al.
The Journal of Clinical Investigation|September 20, 2011
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinomaHideaki Ijichi, Anna Chytil, Agnieszka E Gorska, et al.
Scientific Reports|December 4, 2020
Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancerRyota Takahashi, Hideaki Ijichi, Makoto Sano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2016
PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 ResponsesJiqing Sai, Philip Owens, Sergey V Novitskiy, et al.
Gut|October 22, 2020
Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolismMakoto Sano, Ryota Takahashi, Hideaki Ijichi, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Oncogene|March 1, 2005
Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomyJudith Romero-Gallo, Elif G Sozmen, Anna Chytil, et al.
Cancer Research|January 4, 2014
ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to boneAmanda G Hansen, Shanna A Arnold, Ming Jiang, et al.
Plos One|November 11, 2020
Inhibition of transforming growth factor-β signaling in myeloid cells ameliorates aortic aneurysmal formation in Marfan syndromeHironori Hara, Sonoko Maemura, Takayuki Fujiwara, et al.
The Oncologist|March 13, 2020
Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology DrugsErin P Balogh, Andrew B Bindman, S Gail Eckhardt, et al.
Molecular Cancer Therapeutics|December 21, 2002
Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylaseKeith B Glaser, Junling Li, Mary E Aakre, et al.
Stem Cell Reports|January 27, 2015
Age- and pregnancy-associated DNA methylation changes in mammary epithelial cellsSung Jin Huh, Kendell Clement, David Jee, et al.
The Journal of Clinical Investigation|September 20, 2011
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinomaHideaki Ijichi, Anna Chytil, Agnieszka E Gorska, et al.
Scientific Reports|December 4, 2020
Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancerRyota Takahashi, Hideaki Ijichi, Makoto Sano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2016
PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 ResponsesJiqing Sai, Philip Owens, Sergey V Novitskiy, et al.
Gut|October 22, 2020
Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolismMakoto Sano, Ryota Takahashi, Hideaki Ijichi, et al.
Pageof 12